This report aims to provide a comprehensive presentation of the global market for Antibody Drug Conjugates, with and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibody Drug Conjugates.

The Antibody Drug Conjugates market size considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antibody Drug Conjugates market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antibody Drug Conjugates manufacturers, new entrants, and industry chain related companies in this market with information for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

The global Antibody Drug Conjugates market size in 2023 is 8460.0 million US dollars, and it is expected to be 26159.9 million US dollars by 2030, with a compound annual growth rate of 17.5% expected in 2024-2030.

MARKET COMPETITIVE LANDSCAPE:
The main players in the Antibody Drug Conjugates market include Takeda Pharmaceutical Company Limited, Hoffmann-La Roche Ltd., Pfizer, Inc., AstraZeneca, and Gilead Sciences, Inc.. The share of the top 3 players in the Antibody Drug Conjugates market is XX%.

REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Antibody Drug Conjugates market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:
The report segments the market by Type and Application. Cleavable Linker accounted for XX% of Antibody Drug Conjugates market in 2023. Non-cleavable Linker share of XX%.
Blood Cancer accounted for XX% of the Antibody Drug Conjugates market in 2023. Breast Cancer accounts for XX%.

Chapter Outline
Chapter 1: Introduces the product overview, research purposes, and then includes economic analysis of global regions and inflation analysis,
Chapter 2: Analyzes the Antibody Drug Conjugates manufacturing cost, including manufacturing cost structure, and industrial chain.
Chapter 3: Analysis of the competitive environment of Antibody Drug Conjugates market participants. This mainly includes the revenue and market share of the top players, along with the players” M&A and expansion in recent years.
Chapter 4: Analyzes the main companies in the Antibody Drug Conjugates industry, including their main businesses, products/services, revenue, gross and gross margin.
Chapters 5-7: Segmented the global Antibody Drug Conjugates market by type, application and region. Analyze the revenue of market segments from different perspectives.
Chapters 8-12: Provide North America, EMEA, China, Asia-Pacific and Latin America Antibody Drug Conjugates market type, application, country and player market segmentation revenue data.
Chapter 13: Introduces the market dynamics, the trends factors and drivers factors of the market, and the challenges and restraints faced by manufacturers in the industry.
Chapter 14: The main points and conclusions of the report.

Highlights-Regions

North America
United States
Canada
China
Asia Pacific (Excluding China)
Japan
Korea
Southeast Asia
India
Australia
EMEA
Europe
Germany
France
UK
Italy
Russia
Nordic
Middle East
Africa
Latin America
Brazil
Argentina
Mexico

Player list
Takeda Pharmaceutical Company Limited
Hoffmann-La Roche Ltd.
Pfizer, Inc.
AstraZeneca
Gilead Sciences, Inc.
Astellas Pharma, Inc.
Seagen, Inc.
Daiichi Sankyo Company, Limited
GlaxoSmithKline plc
Adc Therapeutics Saa

Types list
Cleavable Linker
Non-cleavable Linker

Application list
Blood Cancer
Breast Cancer
Ovary Cancer

Table of Content

1 Antibody Drug Conjugates Market Introduction and Overview
1.1 Antibody Drug Conjugates Definition
1.2 Research Purposes
1.3 Currency Rate
1.4 Report Timeline
1.5 Economic Analysis of Global Regions
1.6 Inflation Analysis
2 Antibody Drug Conjugates Business Cost Analysis
2.1 Proportion of Manufacturing Cost Structure
2.1.1 Labor Cost
2.1.2 Operating Expenses
2.2 Antibody Drug Conjugates Industrial Chain Analysis
3 Market Competition by Manufacturers
3.1 Global Antibody Drug Conjugates Revenue and Market Share by Manufacturer
3.2 Manufacturers Antibody Drug Conjugates Production Sites, Area Served, Product Types
3.3 Antibody Drug Conjugates Market Competitive Situation and Trends
3.3.1 Antibody Drug Conjugates Market Concentration Rate
3.3.2 Global Top 5 and Top 10 Players Market Share by Revenue in 2024
3.3.3 Mergers & Acquisitions, Expansion
4 Players Profiles
4.1 Takeda Pharmaceutical Company Limited
4.1.1 Takeda Pharmaceutical Company Limited Company Profile
4.1.2 Antibody Drug Conjugates Product Overview
4.1.3 Takeda Pharmaceutical Company Limited Antibody Drug Conjugates Market Performance (2019-2024)
4.1.4 Takeda Pharmaceutical Company Limited Business Overview
4.2 Hoffmann-La Roche Ltd.
4.2.1 Hoffmann-La Roche Ltd. Company Profile
4.2.2 Antibody Drug Conjugates Product Overview
4.2.3 Hoffmann-La Roche Ltd. Antibody Drug Conjugates Market Performance (2019-2024)
4.2.4 Hoffmann-La Roche Ltd. Business Overview
4.3 Pfizer, Inc.
4.3.1 Pfizer, Inc. Company Profile
4.3.2 Antibody Drug Conjugates Product Overview
4.3.3 Pfizer, Inc. Antibody Drug Conjugates Market Performance (2019-2024)
4.3.4 Pfizer, Inc. Business Overview
4.4 AstraZeneca
4.4.1 AstraZeneca Company Profile
4.4.2 Antibody Drug Conjugates Product Overview
4.4.3 AstraZeneca Antibody Drug Conjugates Market Performance (2019-2024)
4.4.4 AstraZeneca Business Overview
4.5 Gilead Sciences, Inc.
4.5.1 Gilead Sciences, Inc. Company Profile
4.5.2 Antibody Drug Conjugates Product Overview
4.5.3 Gilead Sciences, Inc. Antibody Drug Conjugates Market Performance (2019-2024)
4.5.4 Gilead Sciences, Inc. Business Overview
4.6 Astellas Pharma, Inc.
4.6.1 Astellas Pharma, Inc. Company Profile
4.6.2 Antibody Drug Conjugates Product Overview
4.6.3 Astellas Pharma, Inc. Antibody Drug Conjugates Market Performance (2019-2024)
4.6.4 Astellas Pharma, Inc. Business Overview
4.7 Seagen, Inc.
4.7.1 Seagen, Inc. Company Profile
4.7.2 Antibody Drug Conjugates Product Overview
4.7.3 Seagen, Inc. Antibody Drug Conjugates Market Performance (2019-2024)
4.7.4 Seagen, Inc. Business Overview
4.8 Daiichi Sankyo Company, Limited
4.8.1 Daiichi Sankyo Company, Limited Company Profile
4.8.2 Antibody Drug Conjugates Product Overview
4.8.3 Daiichi Sankyo Company, Limited Antibody Drug Conjugates Market Performance (2019-2024)
4.8.4 Daiichi Sankyo Company, Limited Business Overview
4.9 GlaxoSmithKline plc
4.9.1 GlaxoSmithKline plc Company Profile
4.9.2 Antibody Drug Conjugates Product Overview
4.9.3 GlaxoSmithKline plc Antibody Drug Conjugates Market Performance (2019-2024)
4.9.4 GlaxoSmithKline plc Business Overview
4.10 Adc Therapeutics Saa
4.10.1 Adc Therapeutics Saa Company Profile
4.10.2 Antibody Drug Conjugates Product Overview
4.10.3 Adc Therapeutics Saa Antibody Drug Conjugates Market Performance (2019-2024)
4.10.4 Adc Therapeutics Saa Business Overview
5 Global Antibody Drug Conjugates Historical and Forecast Market Analysis by Type
5.1 Market Size Analysis by Types
5.2 Global Antibody Drug Conjugates Revenue and Market Share by Type
5.3 Global Antibody Drug Conjugates Revenue Market Forecast by Type (2024-2030)
6 Global Antibody Drug Conjugates Historical and Forecast Market Analysis by Application
6.1 Market Size Analysis by Application
6.2 Global Antibody Drug Conjugates Revenue Market Share by Application (2019-2024)
6.3 Antibody Drug Conjugates Revenue Market Forecast by Application (2024-2030)
7 Global Market Growth Trends Analysis
7.1 Global Antibody Drug Conjugates Market Size & Forecast (2019-2030)
7.2 Antibody Drug Conjugates Growth Trends Analysis by Regions
7.2.1 Antibody Drug Conjugates Market Size by Regions: 2019 VS 2024 VS 2030
7.2.2 Antibody Drug Conjugates Historic Revenue Market Size by Regions (2019-2024)
7.2.3 Antibody Drug Conjugates Forecasted Revenue Market Size by Regions (2024-2030)
7.2.4 North America Antibody Drug Conjugates Market Size & Forecast (2019-2030)
7.2.5 EMEA Antibody Drug Conjugates Market Size & Forecast (2019-2030)
7.2.6 China Antibody Drug Conjugates Market Size & Forecast (2019-2030)
7.2.7 Asia-Pacific (Excluding China) Antibody Drug Conjugates Market Size & Forecast (2019-2030)
7.2.8 Latin America Antibody Drug Conjugates Market Size & Forecast (2019-2030)
8 North America
8.1 North America Antibody Drug Conjugates Revenue by Players
8.2 North America Antibody Drug Conjugates Revenue by Types
8.3 North America Antibody Drug Conjugates Revenue by Applications
8.4 North America Antibody Drug Conjugates Market by Countries
8.4.1 North America Antibody Drug Conjugates Revenue by Countries (2019-2030)
8.5 North America SWOT Analysis
8.6 United States
8.7 Canada
9 China
9.1 China Antibody Drug Conjugates Revenue by Players
9.2 China Antibody Drug Conjugates Revenue by Types
9.3 China Antibody Drug Conjugates Revenue by Applications
9.4 China SWOT Analysis
9.5 China
10 Asia Pacific (Excluding China)
10.1 Asia Pacific Antibody Drug Conjugates Revenue by Players
10.2 Asia Pacific Antibody Drug Conjugates Revenue by Types
10.3 Asia Pacific Antibody Drug Conjugates Revenue by Applications
10.4 Asia Pacific Antibody Drug Conjugates Market by Countries
10.4.1 Asia Pacific Antibody Drug Conjugates Revenue by Countries (2019-2030)
10.5 Asia Pacific SWOT Analysis
10.6 Japan
10.7 Korea
10.8 Southeast Asia
10.9 India
10.10 Australia
11 EMEA
11.1 EMEA Antibody Drug Conjugates Revenue by Players
11.2 EMEA Antibody Drug Conjugates Revenue by Types
11.3 EMEA Antibody Drug Conjugates Revenue by Applications
11.4 EMEA Antibody Drug Conjugates Market by Countries
11.4.1 EMEA Antibody Drug Conjugates Revenue by Countries (2019-2030)
11.5 EMEA SWOT Analysis
11.6 Europe
11.6.1 Europe Antibody Drug Conjugates Revenue by Countries (2019-2030)
11.6.2 Germany
11.6.3 France
11.6.4 UK
11.6.5 Italy
11.6.6 Russia
11.6.7 Nordic
11.7 Middle East
11.8 Africa
12 Latin America
12.1 Latin America Antibody Drug Conjugates Revenue by Players
12.2 Latin America Antibody Drug Conjugates Revenue by Types
12.3 Latin America Antibody Drug Conjugates Revenue by Applications
12.4 Latin America Antibody Drug Conjugates Market by Countries
12.4.1 Latin America Antibody Drug Conjugates Revenue by Countries (2019-2030)
12.5 Latin America SWOT Analysis
12.6 Brazil
12.7 Argentina
12.8 Mexico
13 Antibody Drug Conjugates Industry Dynamic Analysis
13.1 Antibody Drug Conjugates Market Trends Analysis
13.2 Antibody Drug Conjugates Market Drivers Analysis
13.3 Antibody Drug Conjugates Market Challenges Analysis
13.4 Antibody Drug Conjugates Market Restraints Analysis
14 Research Findings and Conclusion

List of Tables and Figures

Figure Antibody Drug Conjugates Picture
Table Product Definition of Antibody Drug Conjugates
Table Economic Analysis of Global Regions
Table Inflation Analysis
Table Labor Cost Analysis
Table Operating Expenses Analysis
Figure Antibody Drug Conjugates Industrial Chain Analysis
Table Global Antibody Drug Conjugates Revenue ($) by Manufacturer (2019-2024)
Table Global Antibody Drug Conjugates Revenue Market Share by Manufacturer (2019-2024)
Figure Global Antibody Drug Conjugates Revenue Market Share by Manufacturer in 2024
Table Manufacturers Antibody Drug Conjugates Production Sites, Area Served, Product Types
Table Antibody Drug Conjugates Market Concentration Rate
Figure Global Top 5 and Top 10 Players Market Share by Revenue in 2024
Table Mergers & Acquisitions, Expansion Plans
Table Takeda Pharmaceutical Company Limited Profile
Table Product Overview
Table Takeda Pharmaceutical Company Limited Antibody Drug Conjugates Revenue, Gross and Gross Margin (2019-2024)
Figure Takeda Pharmaceutical Company Limited Revenue and Growth Rate
Figure Takeda Pharmaceutical Company Limited Revenue Market Share 2017-2023
Table Business Overview
Table Hoffmann-La Roche Ltd. Profile
Table Product Overview
Table Hoffmann-La Roche Ltd. Antibody Drug Conjugates Revenue, Gross and Gross Margin (2019-2024)
Figure Hoffmann-La Roche Ltd. Revenue and Growth Rate
Figure Hoffmann-La Roche Ltd. Revenue Market Share 2017-2023
Table Business Overview
Table Pfizer, Inc. Profile
Table Product Overview
Table Pfizer, Inc. Antibody Drug Conjugates Revenue, Gross and Gross Margin (2019-2024)
Figure Pfizer, Inc. Revenue and Growth Rate
Figure Pfizer, Inc. Revenue Market Share 2017-2023
Table Business Overview
Table AstraZeneca Profile
Table Product Overview
Table AstraZeneca Antibody Drug Conjugates Revenue, Gross and Gross Margin (2019-2024)
Figure AstraZeneca Revenue and Growth Rate
Figure AstraZeneca Revenue Market Share 2017-2023
Table Business Overview
Table Gilead Sciences, Inc. Profile
Table Product Overview
Table Gilead Sciences, Inc. Antibody Drug Conjugates Revenue, Gross and Gross Margin (2019-2024)
Figure Gilead Sciences, Inc. Revenue and Growth Rate
Figure Gilead Sciences, Inc. Revenue Market Share 2017-2023
Table Business Overview
Table Astellas Pharma, Inc. Profile
Table Product Overview
Table Astellas Pharma, Inc. Antibody Drug Conjugates Revenue, Gross and Gross Margin (2019-2024)
Figure Astellas Pharma, Inc. Revenue and Growth Rate
Figure Astellas Pharma, Inc. Revenue Market Share 2017-2023
Table Business Overview
Table Seagen, Inc. Profile
Table Product Overview
Table Seagen, Inc. Antibody Drug Conjugates Revenue, Gross and Gross Margin (2019-2024)
Figure Seagen, Inc. Revenue and Growth Rate
Figure Seagen, Inc. Revenue Market Share 2017-2023
Table Business Overview
Table Daiichi Sankyo Company, Limited Profile
Table Product Overview
Table Daiichi Sankyo Company, Limited Antibody Drug Conjugates Revenue, Gross and Gross Margin (2019-2024)
Figure Daiichi Sankyo Company, Limited Revenue and Growth Rate
Figure Daiichi Sankyo Company, Limited Revenue Market Share 2017-2023
Table Business Overview
Table GlaxoSmithKline plc Profile
Table Product Overview
Table GlaxoSmithKline plc Antibody Drug Conjugates Revenue, Gross and Gross Margin (2019-2024)
Figure GlaxoSmithKline plc Revenue and Growth Rate
Figure GlaxoSmithKline plc Revenue Market Share 2017-2023
Table Business Overview
Table Adc Therapeutics Saa Profile
Table Product Overview
Table Adc Therapeutics Saa Antibody Drug Conjugates Revenue, Gross and Gross Margin (2019-2024)
Figure Adc Therapeutics Saa Revenue and Growth Rate
Figure Adc Therapeutics Saa Revenue Market Share 2017-2023
Table Business Overview
Table Global Antibody Drug Conjugates Market Size by Type (2024 VS 2030)
Table Global Antibody Drug Conjugates Revenue and Market Size by Type (2019-2024)
Table Global Antibody Drug Conjugates Revenue and Market Share by Type (2019-2024)
Table Global Antibody Drug Conjugates Revenue Market Size Forecast by Type (2024-2030)
Table Global Antibody Drug Conjugates Revenue Market Share Forecast by Type (2024-2030)
Table Global Antibody Drug Conjugates Market Size by Application (2024 VS 2030)
Table Global Antibody Drug Conjugates Revenue Market Size by Application (2019-2024)
Table Global Antibody Drug Conjugates Revenue Market Share by Application (2019-2024)
Table Global Antibody Drug Conjugates Revenue Market Size by Application (2024-2030)
Table Global Antibody Drug Conjugates Revenue Market Share by Application (2024-2030)
Figure Global Antibody Drug Conjugates Revenue Market Size & Forecast (2019-2030)
Table Antibody Drug Conjugates Market Size by Regions: 2019 VS 2024 VS 2030
Table Antibody Drug Conjugates Historic Revenue Market Size by Regions (2019-2024)
Table Antibody Drug Conjugates Historic Revenue Market Share by Regions (2019-2024)
Table Antibody Drug Conjugates Forecasted Revenue Market Size by Regions (2024-2030)
Table Antibody Drug Conjugates Forecasted Revenue Market Share by Regions (2024-2030)
Figure North America Antibody Drug Conjugates Market Size & Forecast (2019-2030)
Figure EMEA Antibody Drug Conjugates Market Size & Forecast (2019-2030)
Figure China Antibody Drug Conjugates Market Size & Forecast (2019-2030)
Figure Asia-Pacific (Excluding China) Antibody Drug Conjugates Market Size & Forecast (2019-2030)
Figure Latin America Antibody Drug Conjugates Market Size & Forecast (2019-2030)
Table North America Antibody Drug Conjugates Revenue Share by Players 2023
Table North America Antibody Drug Conjugates Revenue by Types (2019-2024)
Table North America Antibody Drug Conjugates Revenue Market Share by Types (2019-2024)
Table North America Antibody Drug Conjugates Revenue by Applications (2019-2024)
Table North America Antibody Drug Conjugates Revenue Market Share by Applications (2019-2024)
Table North America Antibody Drug Conjugates Revenue by Countries (2019-2030)
Table North America Antibody Drug Conjugates Revenue Market Share by Countries (2019-2030)
Table North America SWOT Analysis
Figure United States Antibody Drug Conjugates Revenue and Growth (2019-2030)
Figure Canada Antibody Drug Conjugates Revenue and Growth (2019-2030)
Table China Antibody Drug Conjugates Revenue Share by Players 2023
Table China Antibody Drug Conjugates Revenue by Types (2019-2024)
Table China Antibody Drug Conjugates Revenue Market Share by Types (2019-2024)
Table China Antibody Drug Conjugates Revenue by Applications (2019-2024)
Table China Antibody Drug Conjugates Revenue Market Share by Applications (2019-2024)
Table China SWOT Analysis
Figure China Antibody Drug Conjugates Revenue and Growth (2019-2030)
Table Asia Pacific Antibody Drug Conjugates Revenue Share by Players 2023
Table Asia Pacific Antibody Drug Conjugates Revenue by Types (2019-2024)
Table Asia Pacific Antibody Drug Conjugates Revenue Market Share by Types (2019-2024)
Table Asia Pacific Antibody Drug Conjugates Revenue by Applications (2019-2024)
Table Asia Pacific Antibody Drug Conjugates Revenue Market Share by Applications (2019-2024)
Table Asia-Pacific Antibody Drug Conjugates Revenue by Countries (2019-2030)
Table Asia-Pacific Antibody Drug Conjugates Revenue Market Share by Countries (2019-2030)
Table Asia Pacific SWOT Analysis
Figure Japan Antibody Drug Conjugates Revenue and Growth (2019-2030)
Figure Korea Antibody Drug Conjugates Revenue and Growth (2019-2030)
Figure Southeast Asia Antibody Drug Conjugates Revenue and Growth (2019-2030)
Figure India Antibody Drug Conjugates Revenue and Growth (2019-2030)
Figure Australia Antibody Drug Conjugates Revenue and Growth (2019-2030)
Table EMEA Antibody Drug Conjugates Revenue Share by Players 2023
Table EMEA Antibody Drug Conjugates Revenue by Types (2019-2024)
Table EMEA Antibody Drug Conjugates Revenue Market Share by Types (2019-2024)
Table EMEA Antibody Drug Conjugates Revenue by Applications (2019-2024)
Table EMEA Antibody Drug Conjugates Revenue Market Share by Applications (2019-2024)
Table EMEA Antibody Drug Conjugates Revenue by Countries (2019-2030)
Table EMEA Antibody Drug Conjugates Revenue Market Share by Countries (2019-2030)
Table EMEA SWOT Analysis
Figure Europe Antibody Drug Conjugates Revenue and Growth (2019-2030)
Table Europe Antibody Drug Conjugates Revenue by Countries (2019-2030)
Table Europe Antibody Drug Conjugates Revenue Market Share by Countries (2019-2030)
Figure Germany Antibody Drug Conjugates Revenue and Growth (2019-2030)
Figure France Antibody Drug Conjugates Revenue and Growth (2019-2030)
Figure UK Antibody Drug Conjugates Revenue and Growth (2019-2030)
Figure Italy Antibody Drug Conjugates Revenue and Growth (2019-2030)
Figure Russia Antibody Drug Conjugates Revenue and Growth (2019-2030)
Figure Nordic Antibody Drug Conjugates Revenue and Growth (2019-2030)
Figure Middle East Antibody Drug Conjugates Revenue and Growth (2019-2030)
Figure Africa Antibody Drug Conjugates Revenue and Growth (2019-2030)
Table Latin America Antibody Drug Conjugates Revenue Share by Players 2023
Table Latin America Antibody Drug Conjugates Revenue by Types (2019-2024)
Table Latin America Antibody Drug Conjugates Revenue Market Share by Types (2019-2024)
Table Latin America Antibody Drug Conjugates Revenue by Applications (2019-2024)
Table Latin America Antibody Drug Conjugates Revenue Market Share by Applications (2019-2024)
Table Latin America Antibody Drug Conjugates Revenue by Countries (2019-2030)
Table Latin America Antibody Drug Conjugates Revenue Market Share by Countries (2019-2030)
Table Latin America SWOT Analysis
Figure Brazil Antibody Drug Conjugates Revenue and Growth (2019-2030)
Figure Argentina Antibody Drug Conjugates Revenue and Growth (2019-2030)
Figure Mexico Antibody Drug Conjugates Revenue and Growth (2019-2030)
Table Market Trends Analysis
Table Market Drivers Analysis
Table Market Challenges Analysis
Table Market Restraints Analysis